Golden Cross Stocks — Performance View · Biological Products, (No Diagnostic Substances)
5 stocks match the Golden Cross Stocks screen. Stocks whose 50-day moving average has just crossed above their 200-day — a classic bullish trend signal. Performance columns. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–5 of 5
| GILD | Gilead Sciences | +1.59% | +14.74% | +18.53% | +2.29% | +33.84% | +24.38% | 2.5% | 2.4% | 0.64 | 292K | 151.21 | +1.09% | 186K |
| CRSP | Crispr Therapeutics Ag | -4.84% | +7.60% | -0.76% | -1.60% | +6.62% | +4.97% | 3.4% | 3.9% | 1.06 | 67K | 56.47 | -0.79% | 71K |
| NVAX | Novavax Inc | +14.19% | +34.11% | +1.67% | +3.50% | +39.92% | +45.02% | 7.3% | 5.6% | 0.87 | 263K | 10.34 | +0.19% | 229K |
| ZURA | Zura Bio Ltd | +0.43% | +4.26% | +59.86% | -12.96% | +189.41% | +5.76% | 5.9% | 5.7% | 1.02 | 79K | 5.88 | +3.52% | 81K |
| LIMN | Liminatus Pharma, Inc. | -15.91% | — | — | — | — | — | 7.4% | 13.7% | 0.00 | 995K | 3.70 | -2.89% | 293 |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.